RENOVE
REduced dose versus full-dose of direct oral anticoagulant after uNprOvoked Venous thromboEmbolism. The RENOVE open-label, randomized, controlled trial
Sponsors:
Brest University Hospital
Brest, France
Status:
- Recruitment to stop on June 30, 2022
Design
Open-label RCT comparing a reduced dose versus full-dose of direct oral anticoagulant after unprovoked venous thromboembolism
Participating Sites
Lead Network:
INNOVTE
Countries:
France,Lead Investigators
Francis Couturaud, MD, PhD
Subscribe